Who invested in Dianthus Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$719Mraised across 1 round since 2026, from 1 source

Latest round: Round, $719MMar 2026
Investors: 4

See who backed them

The rounds

Mar 2026
Round$719M
Source recorded

Founders and team

From the SEC filings it signed: 2 on the team.

Kenneth Evan ThompsonExecutive Officeri
Marino GarciaExecutive Officer, Directori

On the board, as filediJonathan Evan ViolinLei Evan MengLeon O. MoulderPaula Evan SoteropoulosTomas Evan Kiselak

Everyone who backed them

RA Capital ManagementPrivate equity1round

Janus Henderson InvestorsPrivate equity1round

Catalio Capital ManagementVC firm1round

RTW Investments LLCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Dianthus Therapeutics

Who invested in Dianthus Therapeutics?

Dianthus Therapeutics's investors include RA Capital Management, Janus Henderson Investors, Catalio Capital Management and RTW Investments LLC.

How much has Dianthus Therapeutics raised?

Dianthus Therapeutics has raised $719M across 1 round since 2026.

When did Dianthus Therapeutics last raise?

Dianthus Therapeutics's most recent round was an Undisclosed round of $719M in Mar 2026.

What was Dianthus Therapeutics's biggest round?

Its most recent round, $719M in Mar 2026, is also its largest on record.

Who backed Dianthus Therapeutics first?

Dianthus Therapeutics's first round on record, in Mar 2026, was backed by RA Capital Management, Janus Henderson Investors and Catalio Capital Management and 1 others.